ApoA1, ApoB, ApoA1/B for Pathogenic Prediction of Chronic Obstructive Pulmonary Disease Complicated by Acute Lower Respiratory Tract Infection: A Cross-Sectional Study

References

• Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease. Ann Intern Med. 2020;173(3):Itc17–itc32. doi:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Soriano JB, Abajobir AA, Abate KH; Global, regional. and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X
   PubMed Web of Science ®Google Scholar
• Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
   PubMedGoogle Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
   PubMed Web of Science ®Google Scholar
• Pelgrim CE, van Ark I, van Berkum RE, et al. Effects of a nutritional intervention on impaired behavior and cognitive function in an emphysematous murine model of COPD with endotoxin-induced lung inflammation. Front Nutr. 2022;9:1010989. doi:10.3389/fnut.2022.1010989
   PubMed Web of Science ®Google Scholar
• Ghosh B, Gaike AH, Pyasi K, et al. Bacterial load and defective monocyte-derived macrophage bacterial phagocytosis in biomass smoke-related COPD. Eur Respir J. 2019;53(2):1702273. doi:10.1183/13993003.02273-2017
   PubMed Web of Science ®Google Scholar
• Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58(1):37–42. doi:10.1136/thorax.58.1.37
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• El-Gazzar AG, Kamel MH, Elbahnasy OKM, El-Naggar ME. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Rev Respir Med. 2020;14(1):111–116. doi:10.1080/17476348.2019.1675517
   PubMed Web of Science ®Google Scholar
• Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol. 2022;19(3):168–179. doi:10.1038/s41569-021-00613-5
   PubMed Web of Science ®Google Scholar
• Deng F, Li D, Lei L, et al. Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20(1):188. doi:10.1186/s12933-021-01381-9
   PubMed Web of Science ®Google Scholar
• Wolska A, Reimund M, Sviridov DO, Amar MJ, Remaley AT. Apolipoprotein Mimetic Peptides: potential New Therapies for Cardiovascular Diseases. Cells. 2021;10(3):597. doi:10.3390/cells10030597
   PubMed Web of Science ®Google Scholar
• Aladjem F, Gofman JW, Lieberman M. Immunochemical studies on human plasma lipoproteins. J Exp Med. 1957;105(1):49–67. doi:10.1084/jem.105.1.49
   PubMed Web of Science ®Google Scholar
• Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families. Prog Lipid Res. 1991;30(2–3):105–138. doi:10.1016/0163-7827(91)90008-S
   PubMed Web of Science ®Google Scholar
• Sacks FM. The apolipoprotein story. Atheroscler Suppl. 2006;7(4):23–27. doi:10.1016/j.atherosclerosissup.2006.05.004
   PubMed Web of Science ®Google Scholar
• Paukner K, Králová Lesná I, Poledne R. Cholesterol in the Cell Membrane-An Emerging Player in Atherogenesis. Int J Mol Sci. 2022;23(1):533. doi:10.3390/ijms23010533
   PubMed Web of Science ®Google Scholar
• Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res. 1992;33(8):1091–1097. doi:10.1016/S0022-2275(20)40761-8
   PubMed Web of Science ®Google Scholar
• Kumar GA, Jafurulla M, Chattopadhyay A. The membrane as the gatekeeper of infection: cholesterol in host-pathogen interaction. Chem Phys Lipids. 2016;199:179–185. doi:10.1016/j.chemphyslip.2016.02.007
   PubMed Web of Science ®Google Scholar
• Kotlyarov S. High-Density Lipoproteins: a Role in Inflammation in COPD. Int J Mol Sci. 2022;23(15):8128. doi:10.3390/ijms23158128
   PubMed Web of Science ®Google Scholar
• Saito H, Lund-Katz S, Phillips MC. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res. 2004;43(4):350–380. doi:10.1016/j.plipres.2004.05.002
   PubMed Web of Science ®Google Scholar
• Rodriguez Reguero JJ, Iglesias Cubero G, Vazquez M, et al. Variation in plasma lipid and lipoprotein concentrations in community-acquired pneumonia a six-month prospective study. Eur J Clin Chem Clin Biochem. 1996;34(3):245–249. doi:10.1515/cclm.1996.34.3.245
   PubMedGoogle Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2023 Report. Global Initiative Chronic Obstructive Lung Dis. 2023.
   Google Scholar
• van der Vorst EPC. High-Density Lipoproteins and Apolipoprotein A1. Subcell Biochem. 2020;94:399–420.
   PubMedGoogle Scholar
• Franceschini G. Apolipoprotein function in health and disease: insights from natural mutations. Eur J Clin Invest. 1996;26(9):733–746. doi:10.1046/j.1365-2362.1996.2120536.x
   PubMed Web of Science ®Google Scholar
• Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers. 2019;11(8):1097. doi:10.3390/cancers11081097
   PubMed Web of Science ®Google Scholar
• Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19(10):1079–1101. doi:10.1038/s41423-022-00902-0
   PubMed Web of Science ®Google Scholar
• Yuan L, Han X, Li W, Ren D, Yang X. Isoorientin Prevents Hyperlipidemia and Liver Injury by Regulating Lipid Metabolism, Antioxidant Capability, and Inflammatory Cytokine Release in High-Fructose-Fed Mice. J Agric Food Chem. 2016;64(13):2682–2689. doi:10.1021/acs.jafc.6b00290
   PubMed Web of Science ®Google Scholar
• Alves-Bezerra M, Cohen DE. Triglyceride Metabolism in the Liver. Compr Physiol. 2017;8(1):1–8. doi:10.1002/cphy.c170012
   PubMed Web of Science ®Google Scholar
• Begue F, Chemello K, Veeren B, et al. Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: preliminary Results from the LIPICOR Cohort Study. Int J Mol Sci. 2023;24(5):4605. doi:10.3390/ijms24054605
   PubMed Web of Science ®Google Scholar